Jul10Thu

Enterprise Ireland companies exported a record €17.1 billion worth of goods and services last year

000661c2-642Enterprise Ireland client companies saw the best export growth and net job creation last year in over a decade, its annual report shows today.

EI companies exported a record €17.1 billion worth of goods and services in 2013, up 8% on the previous year.

They also created a net increase of 5,442 new jobs – the largest net increase in ten years. Enterprise Ireland said this highlights the clear link between strong export growth in new and existing worldwide markets, and job creation here.

To read the entire article, please click HERE.

Jul08Tue

Over 160,000 people working for IDA client firms

Screen Shot 2014-07-08 at 4.02.09 PMThe chief executive of the IDA, Barry O’Leary,  has warned that any loss of competitiveness would have a negative impact on levels of foreign direct investment here.

Mr O’Leary also said that the setting out of a pathway to lower personal taxation here would have a positive effect on winning investment from foreign multinational companies.

To read the entire article, please click HERE.

Jul08Tue

Why choose Northern Ireland?

Screen Shot 2014-07-08 at 3.54.47 PMWhy Northern Ireland?

Check out this video and hear directly from the business, professional and financial services sector on why they set up shop in N. Ireland.

Jul08Tue

IABCN member, Jazz Pharmaceuticals, among medicals showing healthy action

Drugmakers and clinical research providers that aim to boost people’s well-being worldwide are displaying healthy stock price performance themselves.

Ethical drugmakers topped the 197 industry groups tracked by IBD in Monday’s issue, just like they did in the prior six weeks. Leaders hail from around the globe.

Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of six stocks in the group with a highest-possible Composite Rating of 99. The Ireland-based company’s portfolio includes its flagship narcolepsy drug Xyrem, which accounted for 65% of revenue last year, and leukemia drug Erwinaze, which chipped in 20% of sales.

To read more, please click HERE.

Jul02Wed

Busy season for the Irish Chamber

IABCN-15th-AnniversaryWe had a busy winter and spring, full of great events!

Click below for a review of our 2014 events, including our Ambassador’s Awards, Member Spotlights, Executive Perspectives, networking receptions, and more.

 

– 2014 Ambassador’s Awards & Luncheon

– St. Patrick’s Day Parade

– Member Spotlight Series
January: Acumen Analytics ~ view photos ~ download the speaker’s presentation.
April: Cranaleith Spiritual Center
June: Windsor Financial Group ~ view follow-up notes from our speaker

– Executive Perspective Breakfast featuring Edward Hanway, former CEO of Cigna

– Invest in Ireland Seminar ~ view photos ~ download our speakers’ presentations.

– 15th Anniversary Reception

Jun20Fri

Kevin O’Malley, a second-generation Irish American, is to be the next US ambassador to Ireland.

The White House has announced that it has nominated Missouri lawyer Kevin O’Malley as the next US ambassador to Ireland.

The move brings to an end the longest period for which the diplomatic role has been vacant.

A well-known trial lawyer with a long record of public service, Mr O’Malley, a second-generation Irish American, is to fill the role almost 18 months after the last US ambassador, Pittsburgh Steelers owner Dan Rooney, left Dublin.

To read more, please click HERE.

White house defends ambassador appointment delay

The White House Chief of Staff has said the delay in nominating a US Ambassador to Ireland does not mean Ireland is not a priority for the Obama administration.

Denis McDonough said Ireland and Northern Ireland remained a fundamental national priority for the US, and a personal one for president Barack Obama.

To read more, please click HERE.